American Medical Association: Why this Black doctor volunteered for coronavirus vaccine trial

Dr. Louito Edje, UC associate dean and UC Health physician, wanted to support her patients

The American Medical Association interviewed Louito Edje, MD, associate dean of graduate medical education and designated institutional official at the University of Cincinnati College of Medicine, about the race to develop a COVID-19 vaccine and Edje’s decision to take part in a clinical trial.  Too few of the people participating are Black, but it’s not surprising given the long-running difficulty that clinical trials have encountered in recruiting Black research subjects given high levels of historical mistrust.

Lou Edje, MD, MHPE, Graduate Medical Education

Louito Edje, MD

Edge, a professor in the Department Medical Education and the Department of Family and Community Medicine, is also a UC Health physician.  She joined the Phase 3 clinical trial for a SARS-CoV-2 vaccine. UC is one of approximately 90 sites in the U.S. to host a trial for the mRNA-1273 vaccine developed by National Institute of Allergy and Infectious Diseases scientists and collaborators at biotechnology company Moderna.

Her decision to enroll in the federally funded study was an easy one. Edje dedicates many of her working hours overseeing more than 700 resident and fellow physicians who train at UC Health. During the COVID-19 pandemic, that means ensuring learners are safe as they provide frontline care.

Read Dr. Edje’s interview with the American Medical Association online.

Learn more about Dr. Louito Edje online.

Related Stories

2

What is the 'cicada' COVID variant?

April 6, 2026

A formerly rare strain of COVID, BA.3.2, now is showing up in Ohio and 24 other states. Experts say so far it hasn't caused illness any more severe than other strains, but it might be somewhat more resistant to vaccines, as 91.7 WVXU News recently reported. Scientists have nicknamed the variant "cicada" due to its former low profile and current resurgence.

3

UC opens zebrafish research facility to study infertility

April 6, 2026

The University of Cincinnati is launching a state-of-the-art zebrafish research facility that scientists say could help explain how environmental toxins affect fertility, as WKRC-TV/Local 12 and WLWT-TV/Ch. 5 recently reported.